
1. antiviral res. 2006 mar;69(3):181-5. epub 2006 jan 20.

amino acid insertions position 35 hiv-1 protease interfere virus
replication without modifying antiviral drug susceptibility.

paolucci s(1), baldanti f, dossena l, gerna g.

author information: 
(1)servizio di virologia, irccs policlinico san matteo, 27100 pavia, italy.

among 1330 patients undergoing highly active antiretroviral therapy (haart), 3
showed 1 2 amino acid (aa) insertions position 35 hiv-1 protease
gene. protease genes containing aa insertions, either presence
(ins35g+res.muts, ins35tn+res.muts) absence (ins35g, ins35tn) other
resistance mutations, introduced wild-type hiv-1 strain nl4-3. 
introduction ins35g ins35tn wild-type protease confirmed these
mutations per se responsible decreased drug susceptibility. the
replication rate mutant recombinant viruses determined hiv rna
quantification supernatants cell cultures comparison recombinant 
hiv-1 strain wild-type protease. recombinant ins35g ins35tn hiv-1
strains display increased resistance currently used protease
inhibitors (pis). comparison ins35tn+res.muts ins35g+res.muts respect
to corresponding recombinant rescue mutants showed ins35tn decreased the
replication rate pi-resistant strain, ins35g protective
effect.

doi: 10.1016/j.antiviral.2005.12.005 
pmid: 16460817  [indexed medline]

